Nuwellis Announced Results From Two New Clinical Data Analyses From The AVOID-HF Trial Demonstrating Benefits Of Aquadex System For Heart Failure
Nuwellis Announced Results From Two New Clinical Data Analyses From The AVOID-HF Trial Demonstrating Benefits Of Aquadex System For Heart Failure
Nuwellis公佈了AVOID-HF試驗的兩項新臨床數據分析結果，顯示了Aquadex系統對心力衰竭的好處
- Analysis demonstrates the statistically superior benefits of ultrafiltration therapy in heart failure events and heart failure hospitalizations compared to intravenous loop diuretics
- Artificial intelligence and machine learning-based model show that lifestyle and clinical factors can be strong predictors of heart failure events
-分析表明，與靜脈注射迴路利尿劑相比，超濾療法在心力衰竭事件和心力衰竭住院方面具有優異的統計學優勢
-基於人工智能和機器學習的模型表明，生活方式和臨床因素可以有力地預測心力衰竭事件